In this webinar, Stefano Benvenuti will explore how non-profit models — behind Waskyra, the first FDA-approved gene therapy from a non-profit organization — are redefining access for ultra-rare diseases.
In this joint workshop on Gene and Cell Therapy (GCT), translational scientists aiming to bring their work into clinical practice are invited to discuss the current state and future directions of one of the most dynamic fields shaping the future of medicine.